- Home
- OABI vs SLSR Comparison
OABI vs SLSR Comparison
Compare OABI & SLSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OABI
- SLSR
- Stock Information
- Founded
- OABI 2012
- SLSR 2018
- Country
- OABI United States
- SLSR Canada
- Employees
- OABI N/A
- SLSR N/A
- Industry
- OABI Biotechnology: Pharmaceutical Preparations
- SLSR
- Sector
- OABI Health Care
- SLSR
- Exchange
- OABI Nasdaq
- SLSR NYSE
- Market Cap
- OABI 459.1M
- SLSR 462.9M
- IPO Year
- OABI N/A
- SLSR N/A
- Fundamental
- Price
- OABI $4.53
- SLSR $2.35
- Analyst Decision
- OABI Strong Buy
- SLSR Strong Buy
- Analyst Count
- OABI 4
- SLSR 2
- Target Price
- OABI $9.00
- SLSR $7.50
- AVG Volume (30 Days)
- OABI 349.2K
- SLSR 38.3K
- Earning Date
- OABI 11-12-2024
- SLSR 11-18-2024
- Dividend Yield
- OABI N/A
- SLSR N/A
- EPS Growth
- OABI N/A
- SLSR N/A
- EPS
- OABI N/A
- SLSR N/A
- Revenue
- OABI $21,714,000.00
- SLSR N/A
- Revenue This Year
- OABI N/A
- SLSR N/A
- Revenue Next Year
- OABI $71.78
- SLSR N/A
- P/E Ratio
- OABI N/A
- SLSR N/A
- Revenue Growth
- OABI N/A
- SLSR N/A
- 52 Week Low
- OABI $3.56
- SLSR $1.90
- 52 Week High
- OABI $6.72
- SLSR $4.45
- Technical
- Relative Strength Index (RSI)
- OABI 73.77
- SLSR 45.79
- Support Level
- OABI $4.04
- SLSR $2.18
- Resistance Level
- OABI $4.87
- SLSR $2.33
- Average True Range (ATR)
- OABI 0.18
- SLSR 0.10
- MACD
- OABI 0.10
- SLSR 0.01
- Stochastic Oscillator
- OABI 86.09
- SLSR 33.33
About OABI OmniAb Inc.
OmniAb Inc offers therapeutic antibody discovery technologies. The company focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.
About SLSR SOLARIS RESOURCES INC
Solaris Resources Inc is advancing a portfolio of copper and gold assets in the Americas, which includes a high-grade resource with expansion and additional discovery potential at the Warintza copper and gold project in Ecuador; discovery potential on the grass-roots Tamarugo project in Chile and Capricho and Paco Orco projects in Peru, and the La Verde joint venture project.